{
    "clinical_study": {
        "@rank": "70430", 
        "arm_group": [
            {
                "arm_group_label": "RG7314", 
                "arm_group_type": "Experimental"
            }, 
            {
                "arm_group_label": "Placebo", 
                "arm_group_type": "Placebo Comparator"
            }
        ], 
        "brief_summary": {
            "textblock": "This multi-center, randomized, double-blind, parallel group, placebo-controlled, proof of\n      concept study will investigate the efficacy and safety of RG7314 in ad ult patients with\n      autism spectrum disorders (ASD). In stage I of the study, pati ents will be randomized to\n      receive daily oral doses of 1.5 mg RG7314 or placebo for 12 weeks. After an independent\n      safety review, the study may proceed to stage II. In stage II of the study, additional\n      patients will be randomized to receive daily oral doses of 4 mg RG7314 or placebo for 12\n      weeks. The anticipated time o n study treatment is 12 weeks."
        }, 
        "brief_title": "A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders", 
        "completion_date": {
            "#text": "March 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Autistic Disorder", 
        "condition_browse": {
            "mesh_term": [
                "Autistic Disorder", 
                "Child Development Disorders, Pervasive"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Male adult patients, 18 to 45 years of age\n\n          -  Patients meet DSM-5 criteria for ASD and ICD10 criteria for Autism diagnosis\n\n          -  Social Responsiveness Scale > / = 66\n\n          -  Clinical Global Impressions   Severity (CGI-S) > = 4 (moderately ill)\n\n          -  Patients have an IQ > = 70\n\n          -  A body mass index (BMI) between 18 to 40 kg/m2 inclusive\n\n          -  Language, hearing and vision compatible with the study measurements as judged by the\n             investigator\n\n          -  Lives with (or has substantial periods of contact with) a caregiver who is willing\n             and able to attend visits when required, oversee the patient's compliance with\n             protocol-specified procedures and study medication dosing, and report on the\n             patient's status via completion of study assessments. Any period of absence must be\n             covered by another caregiver. Non-cohabitating caregiver(s) must spend sufficient\n             time with the subject so that, in the opinion of the investigator, the caregiver(s)\n             can reliably assess patient's mental status, activities and behavior.\n\n        Exclusion Criteria:\n\n          -  Alcohol and/or substance abuse/dependence during the last 12 months\n\n          -  A significant risk for suicidal behavior, in the opinion of the investigator\n\n          -  Systolic blood pressure greater than 140 or less than 90 mm Hg, and diastolic blood\n             pressure greater than 90 or less than 50 mm Hg\n\n          -  Resting pulse rate greater than 90 or less than 40 beats per minute\n\n          -  Use of prohibited medications or herbal remedies within 2 weeks prior to\n             randomization, or 5 half-lives (whichever is longer)\n\n          -  Initiation of a new major change in psychological intervention within 4 weeks prior\n             to randomization. Minor changes in ongoing treatment are not considered significant\n\n          -  Participation in an investigational drug or device study within 60 days prior\n             screening"
            }, 
            "gender": "Male", 
            "healthy_volunteers": "No", 
            "maximum_age": "45 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "130", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "February 14, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01793441", 
            "org_study_id": "BP28420"
        }, 
        "intervention": [
            {
                "arm_group_label": "RG7314", 
                "description": "Stage I: Daily oral doses of 1.5 mg RG7314 for 12 weeks; Stage II: Daily oral doses of 4 mg RG7314 for 12 weeks", 
                "intervention_name": "RG7314", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Placebo", 
                "description": "Stage I: 1.5mg Placebo to RG7314 for 12 weeks; Stage II: 4mg Placebo to RG7314 for 12 weeks", 
                "intervention_name": "Placebo", 
                "intervention_type": "Drug"
            }
        ], 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "lastchanged_date": "June 3, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Phoenix", 
                        "country": "United States", 
                        "state": "Arizona", 
                        "zip": "85006"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Los Ageles", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "90095"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Sacramento", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "95816"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "San Diego", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "92108"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "San Francisco", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "94115"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Santa Ana", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "92705"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Stanford", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "94305"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Centennial", 
                        "country": "United States", 
                        "state": "Colorado", 
                        "zip": "80112"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "New Haven", 
                        "country": "United States", 
                        "state": "Connecticut", 
                        "zip": "06510"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Delray Beach", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "33445"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Oakland Park", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "33334"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Orlando", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "32806"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Decatur", 
                        "country": "United States", 
                        "state": "Georgia", 
                        "zip": "30033"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Chicago", 
                        "country": "United States", 
                        "state": "Illinois", 
                        "zip": "60612"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Baltimore", 
                        "country": "United States", 
                        "state": "Maryland", 
                        "zip": "21205"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Rockville", 
                        "country": "United States", 
                        "state": "Maryland", 
                        "zip": "20852"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Lexington", 
                        "country": "United States", 
                        "state": "Massachusetts", 
                        "zip": "02421"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Minneapolis", 
                        "country": "United States", 
                        "state": "Minnesota", 
                        "zip": "55414"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bronx", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "10467"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "New York", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "10029"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Orangeburg", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "10962"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Chapel Hill", 
                        "country": "United States", 
                        "state": "North Carolina", 
                        "zip": "27599-7167"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Cincinnati", 
                        "country": "United States", 
                        "state": "Ohio", 
                        "zip": "45229"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Cleveland", 
                        "country": "United States", 
                        "state": "Ohio", 
                        "zip": "44106"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Pittsburgh", 
                        "country": "United States", 
                        "state": "Pennsylvania", 
                        "zip": "15213"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Nashville", 
                        "country": "United States", 
                        "state": "Tennessee", 
                        "zip": "37232"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "San Antonio", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "78258"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bellevue", 
                        "country": "United States", 
                        "state": "Washington", 
                        "zip": "98007"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bothell", 
                        "country": "United States", 
                        "state": "Washington", 
                        "zip": "98011"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Seattle", 
                        "country": "United States", 
                        "state": "Washington", 
                        "zip": "98145"
                    }
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "A Multi-center, Randomized, Double-blind, 12-week, Parallel Group, Placebo-controlled Proof of Concept Study to Investigate the Efficacy and Safety of RG7314 in Individuals With Autism Spectrum Disorders (ASD)", 
        "overall_contact": {
            "email": "global.rochegenentechtrials@roche.com", 
            "last_name": "Reference Study ID Number: BP28420 www.roche.com/about_roche/roche_worldwide.htm", 
            "phone": "888-662-6728 (U.S. Only)"
        }, 
        "overall_official": {
            "affiliation": "Hoffmann-La Roche", 
            "last_name": "Clinical Trials", 
            "role": "Study Director"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "March 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "measure": "Change in social responsiveness scale (SRS-2)", 
                "safety_issue": "No", 
                "time_frame": "From baseline to week 12"
            }, 
            {
                "measure": "Safety: Incidence of adverse events", 
                "safety_issue": "No", 
                "time_frame": "12 weeks"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01793441"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Change in Aberrant Behavior Checklist", 
                "safety_issue": "No", 
                "time_frame": "From baseline to week 12"
            }, 
            {
                "measure": "Change in Repetitive Behavior Scale-Revised", 
                "safety_issue": "No", 
                "time_frame": "From baseline to week 12"
            }, 
            {
                "measure": "Change in Anxiety, Depression and Mood Scale", 
                "safety_issue": "No", 
                "time_frame": "From baseline to week 12"
            }, 
            {
                "measure": "Change in State-Trait Anxiety Inventory", 
                "safety_issue": "No", 
                "time_frame": "From baseline to week 12"
            }, 
            {
                "measure": "Change in Clinical Global Impressions   Severity", 
                "safety_issue": "No", 
                "time_frame": "From baseline to week 12"
            }, 
            {
                "measure": "Change in Clinical Global Impressions   Improvement", 
                "safety_issue": "No", 
                "time_frame": "From baseline to week 12"
            }, 
            {
                "measure": "Change in Vineland-II Adaptive Behavior Scale", 
                "safety_issue": "No", 
                "time_frame": "From baseline to week 12"
            }, 
            {
                "measure": "Pharmacokinetics: plasma concentration of RG7314", 
                "safety_issue": "No", 
                "time_frame": "12 weeks"
            }
        ], 
        "source": "Hoffmann-La Roche", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Hoffmann-La Roche", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "September 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "June 2014"
    }
}